. Compliance wants fairness. The business wants accuracy. At a small scale, you'll be able to’t have all three. At enterprise scale, something surprising happens.
Disclaimer:
The Regulator’s Paradox
You’re a credit risk manager at a mid-sized...
Naver Center Director Ha Jung-woo emphasized that it shouldn't be appropriate to manage the domestic artificial intelligence (AI) market based on the European Union's (EU) AI law model, and somewhat, it's time for lively...
Before a drug is approved by the U.S. Food and Drug Administration (FDA), it must reveal each safety and efficacy. Nevertheless, the FDA doesn't require an understanding a drug’s mechanism of motion for approval....